High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- John M. Kirkwood, MD
UPMC Cancer Center at UPMC Presbyterian
Study Chair - Lawrence E. Flaherty, MD
Barbara Ann Karmanos Cancer Institute
Study Chair - Michael Smylie, MD, MB, ChB
Cross Cancer Institute at University of Alberta
Study Chair - Sanjiv S. Agarwala, MD
St. Luke's Cancer Network at St. Luke's Hospital
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
533 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Westmead Institute for Cancer Research at Westmead Hospital
Westmead, New South Wales, Australia
- Cross Cancer Institute at University of Alberta
Edmonton, Alberta, Canada
- British Columbia Cancer Agency - Centre for the Southern Interior
Kelowna, British Columbia, Canada
- Bcca - Fraser Valley Cancer Centre
Surrey, British Columbia, Canada
- British Columbia Cancer Agency - Vancouver Cancer Centre
Vancouver, British Columbia, Canada
- British Columbia Cancer Agency - Vancouver Island Centre
Victoria, British Columbia, Canada
- Cancercare Manitoba
Winnipeg, Manitoba, Canada
- Nova Scotia Cancer Centre
Halifax, Nova Scotia, Canada
- Royal Victoria Hospital of Barrie
Barrie, Ontario, Canada
- Margaret and Charles Juravinski Cancer Centre
Hamilton, Ontario, Canada
- London Regional Cancer Program at London Health Sciences Centre
London, Ontario, Canada
- R. S. Mclaughlin Durham Regional Cancer Centre at Lakeridge Health Oshawa
Oshawa, Ontario, Canada
- St. Catharines General Hospital at Niagara Health System
St. Catharines, Ontario, Canada
- Edmond Odette Cancer Centre at Sunnybrook
Toronto, Ontario, Canada
- Princess Margaret Hospital
Toronto, Ontario, Canada
- Trillium Health Centre - Mississauga Site
Toronto, Ontario, Canada
- Windsor Regional Cancer Centre at Windsor Regional Hospital
Windsor, Ontario, Canada
- Chum - Hotel Dieu Hospital
Montreal, Quebec, Canada
- Hopital Notre-Dame Du Chum
Montreal, Quebec, Canada
- Mcgill Cancer Centre at Mcgill University
Montreal, Quebec, Canada
- Allan Blair Cancer Centre at Pasqua Hospital
Regina, Saskatchewan, Canada
- Pretoria Academic Hospital
Pretoria, South Africa
- Uab Comprehensive Cancer Center
Birmingham, Alabama, United States
- University of South Alabama Mitchell Cancer Institute
Mobile, Alabama, United States
- Arizona Cancer Center at University of Arizona Health Sciences Center
Tucson, Arizona, United States
- Hembree Mercy Cancer Center at St. Edward Mercy Medical Center
Fort Smith, Arkansas, United States
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Kaiser Permanente - Deer Valley
Antioch, California, United States
- Alta Bates Summit Comprehensive Cancer Center
Berkeley, California, United States
- Peninsula Medical Center
Burlingame, California, United States
- Southern California Permanente Medical Group
Downey, California, United States
- Kaiser Permanente - Fremont
Fremont, California, United States
- Marin Cancer Institute at Marin General Hospital
Greenbrae, California, United States
- Kaiser Permanente Medical Center - Hayward
Hayward, California, United States
- Loma Linda University Cancer Institute at Loma Linda University Medical Center
Loma Linda, California, United States
- Kaiser Permanente Medical Center - Oakland
Oakland, California, United States
- Veterans Affairs Medical Center - Palo Alto
Palo Alto, California, United States
- Kaiser Permanente Medical Center - Redwood City
Redwood City, California, United States
- Kaiser Permanente Medical Center - Richmond
Richmond, California, United States
- Kaiser Permanente Medical Center - Roseville
Roseville, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 25 Mar 1999
- Primary completion
- 31 Jan 2015
- Completion
- 31 Dec 2026
- Last update posted
- 25 Feb 2026
- Registered enrollment
- 1,150
- Registry id
- NCT00003641
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.